$QCOM Qualcomm Inc (QCOM) Overall Average: 96% Buy. Monday,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$QCOM Overall Average: 96% Buy. $QCOR $MRVL $OREX

Qualcomm Inc (QCOM) Buy - Hold - Sell - Overall Opinion

QCOM Last Price: 71.95
Current Change: -1.01 (-1.38%)

Composite Indicators - Signal
TrendSpotter- Buy

Short Term Indicators
7 Day Average Directional Indicator- Buy
10 - 8 Day Moving Average Hilo Channel- Buy
20 Day Moving Average vs Price- Buy
20 - 50 Day MACD Oscillator- Buy
20 Day Bollinger Bands - Hold

Short Term Indicators Average: 80% Buy
20-Day Average Volume - 12,690,614


Medium Term Indicators
40 Day Commodity Channel Index- Buy
50 Day Moving Average vs Price- Buy
20 - 100 Day MACD Oscillator- Buy
50 Day Parabolic Time/Price- Buy

Medium Term Indicators Average: 100% Buy
50-Day Average Volume - 10,502,222

Long Term Indicators
60 Day Commodity Channel Index- Buy
100 Day Moving Average vs Price- Buy
50 - 100 Day MACD Oscillator- Buy

Long Term Indicators Average: 100% Buy
100-Day Average Volume - 11,588,363

Overall Average: 96% Buy

Price - Support - Pivot Point - Resistance
71.95 71.42 72.64 73.86


Last Updated: Monday, November 25, 2013 1:18:58 PM

QCOM Stock Message Board and Forum http://investorshangout.com/search?q=QCOM&...mp;yt0=Go!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ethereum's Path: Staking ETFs and Potential Momentum Gains

Updated Category News Views 97

Ethereum and Its Sideways Trading Ethereum (ETH/USD) is currently experiencing a period of sideways trading. Yet, amidst this stagnation, there is growing speculation regarding the upcoming Ethereum staking ETFs that could invigorate its price movement. Anticipated Breakout and Price Predictions Traders are showing optimism, expecting Ethereum to gradually climb. It’s...

Continue Reading
Editas Medicine Showcases Remarkable Gene Editing Advances in Liver Research

Updated Category News Views 146

Editas Medicine Showcases Gene Editing Breakthroughs In the realm of biotechnology, few areas hold as much promise as gene editing. Editas Medicine, a leader in this field, has taken significant strides towards harnessing the power of this technology for medical advancements. Their latest in vivo proof-of-concept data, which was unveiled at a prestigious annual meeting,...

Continue Reading
Alpha Modus Takes Legal Action Against Cooler Screens for Patent Breach

Updated Category News Views 124

Alpha Modus Initiates Patent Infringement Legal Action Alpha Modus Holdings Inc. (NASDAQ: AMOD), a pioneering company in AI-driven retail engagement technologies, has taken a significant step by filing a patent infringement lawsuit against Cooler Screens, Inc. The lawsuit has been lodged in the Northern District Court of Illinois, outlining serious allegations of...

Continue Reading
Banco Latinoamericano Stock Hits Record Highs Amid Growth

Updated Category News Views 220

Banco Latinoamericano Achieves New Heights In an exciting showcase of financial resilience, Banco Latinoamericano SA (NYSE: BLX) has achieved a remarkable milestone as stock prices soared to an impressive $37.44. This new 52-week high comes at a time of robust growth, with the bank enjoying a market capitalization of approximately $1.37 billion and a price-to-earnings...

Continue Reading
Key Insights on Nucor Corp's Earnings Outlook Ahead

Updated Category News Views 186

Nucor Corp's Upcoming Earnings Report Nucor (NYSE: NUE) is gearing up to unveil its quarterly earnings report soon. Investors are particularly eager to learn how the company has performed over the last few months leading up to this highly anticipated announcement. What Analysts Are Expecting Financial analysts are forecasting Nucor to post an earnings per share (EPS) of...

Continue Reading